UK MHRA Gets A Grip On Spiralling Clinical Trial Assessment Timelines
Executive Summary
The UK medicines regulator says the loss of experienced staff and the need to recruit and train new assessors resulted in temporary delays to clinical trial applications, but the crisis measures it put in place to address the situation mean it has now turned the corner.